LENZ Therapeutics, Inc. (LENZ)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 23
+0.02
+0.3839%
After Hours
$
+0.07 +1.3384% 5. 30
160.22M Market Cap
- P/E Ratio
4.12% Div Yield
603,984 Volume
- Eps
$ 5.21
Previous Close 
Want to track LENZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LENZ Therapeutics, Inc. (LENZ) Statistics
Valuation metrics
Market Cap 160.22M
Enterprise value 136.13M
Trailing P/E (ttm) -1.25
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 7.46
Price/Book (mrq) 0.73
Enterprise Value/Revenue 6.34
Enterprise Value/EBITDA -1.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 631.08K
Average volume (90 days) 913.06K
Price summary
52-Week low 4.54
52-Week high 50.4
Beta -
50-Day moving average 5.03
200-Day moving average 9.77
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Mar 2024
Ex-Dividend Date 22 Mar 2024
Last split factor 1:7
Last split Date 22 Mar 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.87%
Operating margin -6.32%
Operational effectiveness
Return on assets -0.53%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 13.55%
Book value per share (mrq) 6.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
